GLP1R and myocardial ischemia: DPP4i have the potential to be indirectly involved in reducing myocardial ischemia by protecting GLP-1 from degradation, thus GLP-1 receptors, abundantly expressed in renal and cardiovascular tissue, can be further activated [29,30,31,32,33].